EHRA EUROPACE 2013 - European Society of Cardiology
EHRA EUROPACE 2013 - European Society of Cardiology
EHRA EUROPACE 2013 - European Society of Cardiology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
WEdnEsdAy 26 JUnE <strong>2013</strong> - MORNING<br />
08:30 - 10:00 Oral Abstract session Mykonos<br />
Flash abstract presentations: atrial fibrillation ablation<br />
Chairpersons: R. Mantovan (Mestre, it); R. bosch (ludwigsburg, dE)<br />
Each speaker will present and discuss their research. This same research will also be available in a poster<br />
format for discussion and presentation in a dedicated zone <strong>of</strong> the Poster area.<br />
08:54 Patients with atrial fibrillation and left ventricular hypertrophy have significantly<br />
increased mortality when treated with rhythm control strategy: a post-hoc analysis<br />
from AffiRM trial 1318<br />
P. Grover, N. Shah, N. Patel, A. Chothani, K. Mehta, A. Deshmukh, A.O. Badheka,<br />
H. Paydak, J. C<strong>of</strong>fey, J. Viles-Gonzalez (Miami, Staten Island, Washington, Philadelphia<br />
and Little Rock, US)<br />
09:02 endogenous t-PA is an independent predictor <strong>of</strong> adverse cardiovascular events and<br />
all cause death in patients with atrial fibrillation 1319<br />
M.K. Freynh<strong>of</strong>er, D.F. Draxler, S.C. Gruber, V. Bruno, T. Hoechtl, B. Fellner, J. Wojta,<br />
I. Pabinger-Fasching, K. Huber, C. Ay (Vienna, AT)<br />
09:10 thromboembolic complications, mortality and arrhythmia recurrence 6 to 10 years<br />
after catheter ablation <strong>of</strong> atrial fibrillation. 1320<br />
E. Tessitore, N. Tran, P. Gentil-Baron, A.S. Jannot-Berthier, C.I. Park, H. Burri,<br />
H. Sunthorn, F. Mach, D. Shah (Geneva, CH; New York, US)<br />
09:19 left atrial volume and symmetry changes as predictors <strong>of</strong> long-term success after<br />
catheter ablation <strong>of</strong> atrial fibrillation. 1321<br />
S. Nedios, E. Koutalas, S. Pastromas, J. Kosiuk, P. Sommer, A. Arya, S. Rolf, D. Husser,<br />
G. Hindricks, A. Bollmann (Leipzig, DE)<br />
09:27 Digoxin does not influence outcome in patients with permanent atrial fibrillation:<br />
data <strong>of</strong> the RACE ii study 1322<br />
B.A. Mulder, D.J. Van Veldhuisen, H.J.G.M. Crijns, M. Rienstra, J.L. Hillege, J.G.P. Tijssen,<br />
M.P. Van Den Berg, M.A. Alings, I.C. Van Gelder (Groningen, Amsterdam and Breda, NL)<br />
09:35 High incidence <strong>of</strong> ischaemic strokes and left atrial thrombi after left atrial appendage<br />
isolation for treatment <strong>of</strong> atrial tachyarrhythmias 1323<br />
A. Rillig, R.R. Tilz, A. Arya, A. Metzner, S. Mathew, E. Wissner, H. Makimoto,<br />
P. Wohlmuth, K.H. Kuck, F. Ouyang (Hamburg, DE)<br />
09:43 total epicardial adipose tissue volume is associated with outcome <strong>of</strong> pulmonary vein<br />
isolation for atrial fibrillation. 1324<br />
H. Kawakami, K. Satomi, I. Nakajima, K. Miyamoto, Y. Yamada, H. Okamura, T. Noda,<br />
T. Aiba, S. Kamakura, W. Shimizu (Suita, JP)<br />
09:51 Dabigatran versus warfarin in patients undergoing percutaneous atrial fibrillation<br />
ablation: a meta-analysis <strong>of</strong> 3.010 patients. 1325<br />
R.A. Providencia, S. Combes, A. Bouzeman, B. Casteigt, S. Fazaa, H. Hireche, L. Riahi,<br />
S. Boveda, N. Combes, J.P. Albenque (Toulouse, FR)<br />
173<br />
wednesday<br />
sessions
Change language